INS and Hyperglycemia: In the absence of noxious stimuli or with moderate disruptions to the islet microenvironment such as low-level inflammation or hyperglycemia, small EVs transfer regulatory molecules among cells within islets in order to coordinate insulin production and secretion and preserve β-cell viability (26–29).